1. Home
  2. FNWB vs ATYR Comparison

FNWB vs ATYR Comparison

Compare FNWB & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$10.19

Market Cap

82.0M

Sector

Finance

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.79

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
ATYR
Founded
1923
2005
Country
United States
United States
Employees
N/A
58
Industry
Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.0M
73.7M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
FNWB
ATYR
Price
$10.19
$0.79
Analyst Decision
Buy
Hold
Analyst Count
1
9
Target Price
$13.50
$3.67
AVG Volume (30 Days)
63.8K
933.7K
Earning Date
05-05-2026
05-01-2026
Dividend Yield
0.68%
N/A
EPS Growth
36.00
N/A
EPS
N/A
N/A
Revenue
$176,000.00
N/A
Revenue This Year
$19.24
N/A
Revenue Next Year
$8.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.05
$0.64
52 Week High
$10.98
$7.29

Technical Indicators

Market Signals
Indicator
FNWB
ATYR
Relative Strength Index (RSI) 65.33 44.35
Support Level $9.26 $0.68
Resistance Level $10.33 $0.86
Average True Range (ATR) 0.33 0.05
MACD 0.08 0.00
Stochastic Oscillator 84.96 30.16

Price Performance

Historical Comparison
FNWB
ATYR

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It offers various products and services, such as commercial business loans, multi-family real estate loans, auto and consumer loans, transaction accounts, savings and money market accounts, online banking services, etc., focused on the lending, deposit, and money movement needs of individuals, businesses and nonprofit organizations. The Group's operations are mainly focused on serving various communities in Washington State, U.S. Substantially all of its income is derived from a diverse base of commercial, mortgage, and consumer lending activities and investments.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: